Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Recalled August 9, 2023 · FDA recall D-1069-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: Lack of validation data for sanitization cycles · FDA Class II
Units
295 bags
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Product
fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →